Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40

Bibliographic Details
Main Authors:	Richard G. Langley, MD, Chiranjeev Sanyal, PhD, Aaron Situ, MSc, Sarah Alulis, MSc, Fareen Hassan, MSc, Steve Peterson, MPH, Rachel E. Teneralli, PhD, Jennifer Lee, MBA, Barkha P. Patel, PhD, Tim Disher, PhD
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	JAAD International
Subjects:	change from baseline guselkumab indirect treatment comparisons matching-adjusted indirect comparison risankizumab PASI
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328724000166

Internet